<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "http://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1" specific-use="sps-1.9" xml:lang="pt">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id specific-use="scielo-v3" pub-id-type="publisher-id">8MHrGFRTgR4db74hDXzbmwS</article-id>
      <article-id specific-use="scielo-v2" pub-id-type="publisher-id">S0066-782X2025000400301</article-id>
      <article-id pub-id-type="other">00301</article-id>
      <article-id pub-id-type="doi">10.36660/abc.20240607</article-id>
      <article-id pub-id-type="publisher-id">abc.20240607</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigo Original</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Par&#226;metro que Prev&#234; Fibrila&#231;&#227;o Atrial P&#243;s-Operat&#243;ria em Pacientes com Cirurgia de Revasculariza&#231;&#227;o Mioc&#225;rdica: &#205;ndice de Triglicer&#237;deos-Colesterol-Peso Corporal</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-7594-0203</contrib-id>
          <name>
            <surname>Koyuncu</surname>
            <given-names>&#304;lhan</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa e Reda&#231;&#227;o do manuscrito</role>
          <role>Obten&#231;&#227;o de dados</role>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados</role>
          <role>An&#225;lise estat&#237;stica e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-9823-1613</contrib-id>
          <name>
            <surname>Koyun</surname>
            <given-names>Emin</given-names>
          </name>
          <role>Obten&#231;&#227;o de dados</role>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados</role>
          <role>An&#225;lise estat&#237;stica e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do</role>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <aff id="aff1">
          <label>1</label>
          <institution content-type="orgname">Bakircay University</institution>
          <institution content-type="orgdiv1">Cigli Training and Research Hospital</institution>
          <institution content-type="orgdiv2">Department of Cardiology</institution>
          <addr-line>
            <named-content content-type="city">&#304;zmir</named-content>
          </addr-line>
          <country country="TR">Turquia</country>
          <institution content-type="original">Department of Cardiology, Bakircay University, Cigli Training and Research Hospital, &#304;zmir - Turquia</institution>
        </aff>
        <aff id="aff2">
          <label>2</label>
          <institution content-type="orgname">Sivas Numune Hospital</institution>
          <institution content-type="orgdiv1">Department of Cardiology</institution>
          <addr-line>
            <named-content content-type="city">Sivas</named-content>
          </addr-line>
          <country country="TR">Turquia</country>
          <institution content-type="original">Department of Cardiology, Sivas Numune Hospital, Sivas - Turquia</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1"><label>Correspond&#234;ncia:</label><bold>&#304;lhan Koyuncu</bold> &#8226; Bakircay University, Cigli Training and Research Hospital - Yeni Mahalle, 8780/1. Sk. No:18, <postal-code>35620</postal-code> &#199;i&#287;li, &#304;zmir &#8211; Turquia E-mail: <email>dr_ilhann@hotmail.com</email> </corresp>
        <fn fn-type="conflict">
          <label>Potencial conflito de interesse</label>
          <p>N&#227;o h&#225; conflito com o presente artigo</p>
        </fn>
        <fn fn-type="edited-by">
          <label>Editor respons&#225;vel pela revis&#227;o:</label>
          <p>Alexandre Colafranceschi</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>31</day>
        <month>03</month>
        <year>2025</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2025</year>
      </pub-date>
      <volume>122</volume>
      <issue>4</issue>
      <elocation-id>e20240607</elocation-id>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>09</month>
          <year>2024</year>
        </date>
        <date date-type="rev-recd">
          <day>10</day>
          <month>11</month>
          <year>2024</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>02</month>
          <year>2025</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p>Este &#233; um artigo de acesso aberto distribu&#237;do sob os termos da licen&#231;a de atribui&#231;&#227;o pelo Creative Commons</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Resumo</title>
        <sec>
          <title>Fundamento:</title>
          <p>A fibrila&#231;&#227;o atrial p&#243;s-operat&#243;ria (FAPO) &#233; uma complica&#231;&#227;o comum ap&#243;s cirurgia card&#237;aca, particularmente cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica (CRM). Apesar dos avan&#231;os nas t&#233;cnicas cir&#250;rgicas, a FAPO continua sendo uma causa significativa de morbidade e mortalidade.</p>
        </sec>
        <sec>
          <title>Objetivos:</title>
          <p>Este estudo investiga o potencial do &#205;ndice de Triglicer&#237;deos-Colesterol-Peso Corporal (ITCC) como um preditor de FAPO, com foco no impacto do estado nutricional nos resultados cir&#250;rgicos.</p>
        </sec>
        <sec>
          <title>M&#233;todos:</title>
          <p>Este estudo retrospectivo incluiu 321 pacientes submetidos &#224; CRM entre janeiro de 2010 e janeiro de 2024. O ITCC foi calculado usando amostras de sangue pr&#233;-operat&#243;rias e comparado entre aqueles que desenvolveram FAPO e aqueles que n&#227;o desenvolveram. An&#225;lises estat&#237;sticas, incluindo regress&#227;o de Cox e an&#225;lise ROC, foram realizadas para avaliar o valor preditivo do ITCC para FAPO. P&lt;0,05 foi considerado estatisticamente significativo.</p>
        </sec>
        <sec>
          <title>Resultados:</title>
          <p>Pacientes que desenvolveram FAPO apresentaram ITCC significativamente menor (1790,8 &#177; 689, 3413,3 &#177; 1232, p &lt; 0,001, respectivamente) n&#237;veis em compara&#231;&#227;o com aqueles sem FAPO. Al&#233;m disso, a idade (p &lt; 0,001), a frequ&#234;ncia de hipertens&#227;o (p = 0,009), PCR (p = 0,03) e valores de leuc&#243;citos (p = 0,02) tamb&#233;m foram significativamente maiores em pacientes que desenvolveram FAPO. O ITCC foi identificado como um preditor independente de FAPO (OR: 0,998, IC de 95%: 0,997-0,999, p &lt; 0,001), com um valor de corte de 1932,4 prevendo FAPO com sensibilidade de 75% e especificidade de 78%.</p>
        </sec>
        <sec>
          <title>Conclus&#227;o:</title>
          <p>O ITCC &#233; um indicador confi&#225;vel para prever FAPO em pacientes com CRM. A identifica&#231;&#227;o pr&#233;-operat&#243;ria de pacientes com baixo ITCC pode levar a interven&#231;&#245;es direcionadas, reduzindo complica&#231;&#245;es p&#243;s-operat&#243;rias e melhorando os resultados. Otimizar o estado nutricional antes da cirurgia pode mitigar o risco de FAPO.</p>
        </sec>
      </abstract>
      <abstract abstract-type="graphical">
        <p>
          <fig id="f01">
            <label>Figura Central</label>
            <caption>
              <title>: Par&#226;metro que Prev&#234; Fibrila&#231;&#227;o Atrial P&#243;s-Operat&#243;ria em Pacientes com Cirurgia de Revasculariza&#231;&#227;o Mioc&#225;rdica: &#205;ndice de Triglicer&#237;deos-Colesterol-Peso Corporal</title>
            </caption>
            <alternatives>
              <graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/8MHrGFRTgR4db74hDXzbmwS/063dbd83925edd9bc526502b6c38deb3cb8ee7c6.tif"/>
              <graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/8MHrGFRTgR4db74hDXzbmwS/7ed8c225f40d8329e7dd911704a89abc067fbb25.png" specific-use="scielo-web"/>
              <graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/8MHrGFRTgR4db74hDXzbmwS/c4674b86d96070978ab8f7096a6b2a6dd5237adb.jpg" specific-use="scielo-web" content-type="scielo-267x140"/>
            </alternatives>
          </fig>
        </p>
      </abstract>
      <kwd-group xml:lang="pt">
        <title>Palavras-chave:</title>
        <kwd>Fibrila&#231;&#227;o Atrial P&#243;s-Operat&#243;ria</kwd>
        <kwd>&#205;ndice de Triglicer&#237;deos-Colesterol-Peso Corporal</kwd>
        <kwd>Revasculariza&#231;&#227;o do Mioc&#225;rdio Coron&#225;rio</kwd>
        <kwd>Nutri&#231;&#227;o</kwd>
      </kwd-group>
      <counts>
        <fig-count count="4"/>
        <table-count count="4"/>
        <equation-count count="2"/>
        <ref-count count="25"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introdu&#231;&#227;o</title>
      <p>A fibrila&#231;&#227;o atrial (FA) &#233; uma das complica&#231;&#245;es comuns ap&#243;s cirurgia card&#237;aca e continua sendo o tipo mais prevalente de arritmia ap&#243;s a cirurgia. A fibrila&#231;&#227;o atrial p&#243;s-operat&#243;ria (FAPO) &#233; definida como FA que se desenvolve dentro de 1 a 5 dias ap&#243;s cirurgia card&#237;aca em pacientes sem diagn&#243;stico pr&#233;vio de FA. Felizmente, a FAPO frequentemente se converte em ritmo sinusal (RS) espontaneamente dentro das primeiras 24 horas.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> Estudos descobriram que a FAPO se desenvolve em 25% a 50% dos pacientes, dependendo do tipo de procedimento cir&#250;rgico.<sup><xref ref-type="bibr" rid="B2">2</xref></sup></p>
      <p>O efeito do estado nutricional nos resultados da cirurgia cardiovascular &#233; reconhecido h&#225; muito tempo. A nutri&#231;&#227;o inadequada aumenta o risco de complica&#231;&#245;es p&#243;s-operat&#243;rias ao melhorar processos como inflama&#231;&#227;o e estresse oxidativo. Particularmente em grandes interven&#231;&#245;es cir&#250;rgicas como a cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica (CRM), um bom estado nutricional no per&#237;odo pr&#233;-operat&#243;rio pode acelerar a recupera&#231;&#227;o p&#243;s-operat&#243;ria e reduzir a mortalidade.<sup><xref ref-type="bibr" rid="B3">3</xref></sup> Indicadores nutricionais simples e acess&#237;veis, como triglicer&#237;deos, colesterol total e &#237;ndice de peso corporal (ITCC), s&#227;o ferramentas importantes para avaliar o estado nutricional no per&#237;odo pr&#233;-operat&#243;rio. Baixos n&#237;veis de ITCC s&#227;o considerados um sinal de desnutri&#231;&#227;o e t&#234;m se mostrado eficazes na previs&#227;o de eventos cardiovasculares em pacientes com doen&#231;a arterial coronariana.<sup><xref ref-type="bibr" rid="B4">4</xref></sup> Portanto, otimizar o suporte nutricional antes de grandes cirurgias como CRM &#233; crucial para reduzir complica&#231;&#245;es p&#243;s-operat&#243;rias. A nutri&#231;&#227;o inadequada n&#227;o s&#243; aumenta o risco de complica&#231;&#245;es p&#243;s-operat&#243;rias, mas tamb&#233;m afeta negativamente a qualidade de vida geral e a sobrevida em longo prazo. Indicadores como o ITCC s&#227;o ferramentas valiosas para prever esses riscos e aplicar interven&#231;&#245;es nutricionais preventivas. Nesse contexto, avaliar com precis&#227;o o estado nutricional dos pacientes antes da cirurgia &#233; uma etapa cr&#237;tica para prevenir complica&#231;&#245;es</p>
      <p>Apesar dos avan&#231;os nas t&#233;cnicas cir&#250;rgicas e tratamentos perioperat&#243;rios, a incid&#234;ncia de FAPO n&#227;o diminuiu ao longo do tempo. A FAPO continua a contribuir para o aumento da morbidade e mortalidade p&#243;s-operat&#243;ria.<sup><xref ref-type="bibr" rid="B5">5</xref></sup> Al&#233;m disso, continua sendo um fator significativo nos custos de sa&#250;de.<sup><xref ref-type="bibr" rid="B6">6</xref></sup> Notavelmente, a FA &#233; observada com mais frequ&#234;ncia em pacientes com FAPO em compara&#231;&#227;o com aqueles em RS p&#243;s-operat&#243;rio.<sup><xref ref-type="bibr" rid="B7">7</xref></sup></p>
      <p>V&#225;rios estudos demonstraram que a FAPO est&#225; associada a um aumento da incid&#234;ncia de complica&#231;&#245;es a curto prazo, particularmente ap&#243;s CRM.<sup><xref ref-type="bibr" rid="B8">8</xref></sup> Al&#233;m disso, estudos de longo prazo demonstraram que a FAPO est&#225; associada a um aumento do risco de morte e complica&#231;&#245;es tromboemb&#243;licas.<sup><xref ref-type="bibr" rid="B9">9</xref></sup></p>
      <p>Nos &#250;ltimos anos, a pesquisa tem se concentrado em marcadores bioqu&#237;micos e metab&#243;licos que podem prever FAPO, especialmente porque estrat&#233;gias preventivas podem mitigar riscos associados. Um desses marcadores &#233; o ITCC, calculado como:</p>
      <disp-formula id="eq1">
        <mml:math display="block" id="m01">
          <mml:mrow>
            <mml:mtext>ITCC</mml:mtext>
            <mml:mo>=</mml:mo>
            <mml:mfrac>
              <mml:mrow>
                <mml:mtext>Triglicer&#237;deos (mg/dL)</mml:mtext>
                <mml:mo>&#215;</mml:mo>
                <mml:mtext>Colesterol total(mg/dL)</mml:mtext>
                <mml:mo>&#215;</mml:mo>
                <mml:mtext>Peso corporal(kg)</mml:mtext>
              </mml:mrow>
              <mml:mrow>
                <mml:mn>1.000</mml:mn>
              </mml:mrow>
            </mml:mfrac>
          </mml:mrow>
        </mml:math>
      </disp-formula>
      <p>Estudos anteriores mostraram que o ITCC &#233; um marcador cr&#237;tico em pacientes com insufici&#234;ncia card&#237;aca,<sup><xref ref-type="bibr" rid="B10">10</xref></sup> doen&#231;a arterial coronariana,<sup><xref ref-type="bibr" rid="B4">4</xref></sup> doen&#231;a cr&#237;tica,<sup><xref ref-type="bibr" rid="B11">11</xref></sup> bem como na popula&#231;&#227;o em geral e pacientes com AVC.<sup><xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref></sup> No entanto, a rela&#231;&#227;o entre ITCC e FA, particularmente FAPO, permanece inexplorada. O estado nutricional inadequado n&#227;o s&#243; aumenta o risco de complica&#231;&#245;es p&#243;s-operat&#243;rias, mas tamb&#233;m afeta negativamente a qualidade de vida geral e a sobrevida em longo prazo. Indicadores como o ITCC s&#227;o ferramentas valiosas para prever esses riscos e aplicar interven&#231;&#245;es nutricionais preventivas. Portanto, avaliar com precis&#227;o o estado nutricional dos pacientes antes da cirurgia &#233; uma etapa cr&#237;tica na preven&#231;&#227;o de complica&#231;&#245;es.</p>
    </sec>
    <sec>
      <title>Objetivo do estudo</title>
      <p>Este estudo tem como objetivo investigar a rela&#231;&#227;o entre ITCC e FAPO calculando ITCC a partir de amostras de sangue coletadas antes da CRM. Se uma associa&#231;&#227;o significativa for encontrada, pode ser poss&#237;vel identificar pacientes de alto risco no pr&#233;-operat&#243;rio e monitor&#225;-los de perto ap&#243;s a cirurgia. Isso pode levar &#224; redu&#231;&#227;o da morbidade e mortalidade em pacientes propensos a desenvolver FAPO, oferecendo um novo caminho para cuidados preventivos com base em fatores de risco nutricionais e metab&#243;licos.</p>
    </sec>
    <sec sec-type="methods">
      <title>M&#233;todos</title>
      <sec>
        <title>Popula&#231;&#227;o de pacientes e defini&#231;&#227;o de ITCC</title>
        <p>Nosso estudo foi desenhado retrospectivamente. Entre janeiro de 2010 e janeiro de 2024, 321 pacientes consecutivos que passaram por CRM em nosso centro foram inclu&#237;dos no estudo. O desenho do estudo e o fluxograma s&#227;o mostrados na <xref ref-type="fig" rid="f01">Ilustra&#231;&#227;o Central</xref>. Os prontu&#225;rios dos pacientes foram avaliados retrospectivamente. Os eletrocardiogramas (ECG) dos pacientes inclu&#237;dos no estudo, feitos antes da CRM, estavam em RS. Os pacientes foram divididos em dois grupos: aqueles que desenvolveram FA p&#243;s-operat&#243;ria e aqueles que n&#227;o desenvolveram. Caracter&#237;sticas demogr&#225;ficas, ITCC e par&#226;metros sangu&#237;neos de ambos os grupos foram comparados. O ITCC foi calculado com esta f&#243;rmula: &#8216;Triglicer&#237;deos x Colesterol total x Peso corporal/1.000&#8217;. O comit&#234; de &#233;tica local aprovou o presente estudo. Nosso estudo foi realizado em conformidade com as diretrizes &#233;ticas da Declara&#231;&#227;o de Helsinque.</p>
        <p>Crit&#233;rios para inclus&#227;o no estudo: foram definidos como n&#227;o ter diagn&#243;stico pr&#233;vio de FA, ter sido submetido a cirurgia de revasculariza&#231;&#227;o do mioc&#225;rdio e ter um ECG sinusal documentado antes da cirurgia.</p>
        <p>Crit&#233;rios de exclus&#227;o: pacientes com dist&#250;rbios eletrol&#237;ticos, pacientes com doen&#231;as valvares card&#237;acas graves e insufici&#234;ncia renal cr&#244;nica, pacientes com marcapassos, pacientes em uso de medicamentos antiarr&#237;tmicos, pacientes com dist&#250;rbios metab&#243;licos e pacientes sem ECG de RS pr&#233;-operat&#243;rio.</p>
        <p>A defini&#231;&#227;o de FAPO foi feita da seguinte forma: em 5 dias ap&#243;s a cirurgia card&#237;aca, a arritmia com dura&#231;&#227;o superior a 10 minutos resolveu-se espontaneamente ou foi tratada com cardiovers&#227;o el&#233;trica/m&#233;dica.<sup><xref ref-type="bibr" rid="B14">14</xref></sup> Os pacientes foram monitorados de perto para arritmia durante toda a sua estadia no hospital. Um ECG tamb&#233;m foi feito quando ocorreram sintomas card&#237;acos, como palpita&#231;&#245;es. Os ECGs dos pacientes foram registrados em 12 deriva&#231;&#245;es nas configura&#231;&#245;es de 10 mm/mVe 25 mm/s.</p>
      </sec>
      <sec>
        <title>An&#225;lise estat&#237;stica</title>
        <p>Histograma, gr&#225;fico q-q e teste de Shapiro-Wilk foram usados para avaliar se os dados violavam as suposi&#231;&#245;es de normalidade. Um teste-T de duas amostras foi realizado para comparar vari&#225;veis cont&#237;nuas entre os grupos. A an&#225;lise qui-quadrado foi usada para avaliar a rela&#231;&#227;o entre vari&#225;veis categ&#243;ricas. Os dados cont&#237;nuos foram apresentados como m&#233;dia &#177; desvio padr&#227;o (DP) com base na distribui&#231;&#227;o dos dados. As vari&#225;veis categ&#243;ricas foram expressas como o n&#250;mero (n) com uma porcentagem (%). A an&#225;lise de regress&#227;o de Cox foi usada para determinar os fatores de risco que afetam o estado de FAPO. As vari&#225;veis que foram consideradas estatisticamente significativas como resultado da an&#225;lise de regress&#227;o de Cox foram avaliadas com an&#225;lise de regress&#227;o de Cox univariada e multivariada. A an&#225;lise ROC (Receiver Operating Characteristic) foi realizada para avaliar o &#237;ndice ITCC e a idade na predi&#231;&#227;o de FAPO. A &#225;rea sob a curva e o valor de corte foram calculados para cada valor de par&#226;metro. A sensibilidade e a especificidade foram calculadas para determinar o poder diagn&#243;stico dos escores. Foi aceito que os valores-p deveriam ser &lt; 0,05 para que os par&#226;metros fossem estatisticamente significativos. A an&#225;lise dos dados foi realizada no software estat&#237;stico SPSS 22.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Resultados</title>
      <p>Entre os 321 pacientes inclu&#237;dos no estudo, o n&#250;mero de pacientes que desenvolveram FAPO ap&#243;s CRM foi de 62. Quando as caracter&#237;sticas cl&#237;nicas e demogr&#225;ficas basais de ambos os grupos foram comparadas, a idade dos pacientes no grupo FAPO era maior do que no outro grupo. O n&#250;mero de hipertens&#227;o tamb&#233;m foi maior no grupo FAPO do que no outro grupo. O valor de prote&#237;na C-reativa (PCR) tamb&#233;m foi maior no grupo FAPO em compara&#231;&#227;o com o outro grupo. O valor de GB tamb&#233;m foi maior no grupo FAPO. Al&#233;m disso, o ITCC foi menor no grupo FAPO do que no outro grupo. N&#227;o houve diferen&#231;a significativa entre os grupos, exceto em idade, hipertens&#227;o, PCR, GB e ITCC (<xref ref-type="table" rid="t1">Tabela 1</xref>).</p>
      <table-wrap id="t1">
        <label>Tabela 1</label>
        <caption>
          <title>Compara&#231;&#227;o das caracter&#237;sticas cl&#237;nicas, demogr&#225;ficas e laboratoriais basais entre os grupos</title>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup width="25%">
            <col/>
            <col/>
            <col/>
            <col/>
          </colgroup>
          <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
            <tr style="background-color:#76B4D0;">
              <th align="left" valign="middle"/>
              <th align="center" valign="middle">Grupo FAPO (-)<break/>(n = 259)</th>
              <th align="center" valign="middle">Grupo FAPO (+)<break/>(n = 62)</th>
              <th align="center" valign="middle">Valor p</th>
            </tr>
          </thead>
          <tbody style="border-bottom: thin solid; border-color: #000000">
            <tr>
              <td align="left" valign="middle">Idade, anos</td>
              <td align="center" valign="middle">61,96 &#177; 9,3</td>
              <td align="center" valign="middle">67,09 &#177; 6,5</td>
              <td align="center" valign="middle">&lt;0,001</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">G&#234;nero feminino, n (%)</td>
              <td align="center" valign="middle">65 (25,1)</td>
              <td align="center" valign="middle">16 (25,8)</td>
              <td align="center" valign="middle">0,08</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Altura (cm)</td>
              <td align="center" valign="middle">170&#177;7,1</td>
              <td align="center" valign="middle">169,3&#177;7,3</td>
              <td align="center" valign="middle">0,72</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">Peso corporal (kg)</td>
              <td align="center" valign="middle">75,2&#177;11,1</td>
              <td align="center" valign="middle">77,6&#177;10,6</td>
              <td align="center" valign="middle">0,45</td>
            </tr>
            <tr>
              <td align="left" valign="middle">IMC (kg/m<sup>2</sup>)</td>
              <td align="center" valign="middle">26,80 &#177; 3,25</td>
              <td align="center" valign="middle">27,41 &#177; 3,36</td>
              <td align="center" valign="middle">0,67</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">Hipertens&#227;o, n (%)</td>
              <td align="center" valign="middle">190 (73,3)</td>
              <td align="center" valign="middle">55 (88)</td>
              <td align="center" valign="middle">0,009</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Diabetes Mellitus, n (%)</td>
              <td align="center" valign="middle">120 (46,3)</td>
              <td align="center" valign="middle">26 (41,9)</td>
              <td align="center" valign="middle">0,35</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">Hiperlipidemia, n (%)</td>
              <td align="center" valign="middle">230 (88,8)</td>
              <td align="center" valign="middle">55 (88,7)</td>
              <td align="center" valign="middle">0,81</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Tabagismo, n (%)</td>
              <td align="center" valign="middle">121 (46,7)</td>
              <td align="center" valign="middle">22 (35,4)</td>
              <td align="center" valign="middle">0,08</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">PA sist&#243;lica (mmHg)</td>
              <td align="center" valign="middle">136,6 &#177; 12,8</td>
              <td align="center" valign="middle">139,1 &#177; 16,5</td>
              <td align="center" valign="middle">0,10</td>
            </tr>
            <tr>
              <td align="left" valign="middle">PA diast&#243;lica (mmHg)</td>
              <td align="center" valign="middle">78,1 &#177; 8,3</td>
              <td align="center" valign="middle">79,3 &#177; 7,5</td>
              <td align="center" valign="middle">0,25</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">Creatinina (mg/dl)</td>
              <td align="center" valign="middle">0,9 &#177; 0,1</td>
              <td align="center" valign="middle">0,8 &#177; 0,15</td>
              <td align="center" valign="middle">0,17</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Na (mmol/L)</td>
              <td align="center" valign="middle">138,7 &#177; 3,1</td>
              <td align="center" valign="middle">137,1 &#177; 2,2</td>
              <td align="center" valign="middle">0,90</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">K (mmol/L)</td>
              <td align="center" valign="middle">4,2 &#177; 0,2</td>
              <td align="center" valign="middle">4,3 &#177; 0,4</td>
              <td align="center" valign="middle">0,30</td>
            </tr>
            <tr>
              <td align="left" valign="middle">AST (U/L)</td>
              <td align="center" valign="middle">34 &#177;5,8</td>
              <td align="center" valign="middle">36&#177;7,3</td>
              <td align="center" valign="middle">0,50</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">ALT (U/L)</td>
              <td align="center" valign="middle">31 &#177;6,6</td>
              <td align="center" valign="middle">36&#177;9,2</td>
              <td align="center" valign="middle">0,51</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Colesterol total</td>
              <td align="center" valign="middle">234,3 &#177; 14,5</td>
              <td align="center" valign="middle">221,5 &#177; 15,1</td>
              <td align="center" valign="middle">0,60</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">LDL-C</td>
              <td align="center" valign="middle">146,5 &#177; 9,2</td>
              <td align="center" valign="middle">159,1 &#177; 9,6</td>
              <td align="center" valign="middle">0,12</td>
            </tr>
            <tr>
              <td align="left" valign="middle">PCR</td>
              <td align="center" valign="middle">62,6 &#177; 34,3</td>
              <td align="center" valign="middle">74 &#177; 38</td>
              <td align="center" valign="middle">0,03</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">Leuc&#243;citos (103/&#181;L)</td>
              <td align="center" valign="middle">10,08 &#177; 3,5</td>
              <td align="center" valign="middle">11,7 &#177;4,7</td>
              <td align="center" valign="middle">0,02</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Neutr&#243;filo (103/uL)</td>
              <td align="center" valign="middle">8,6&#177;0,9</td>
              <td align="center" valign="middle">8,9 &#177;1,3</td>
              <td align="center" valign="middle">0,45</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">Hemoglobina (g/dL)</td>
              <td align="center" valign="middle">10,5 &#177; 1,2</td>
              <td align="center" valign="middle">11 &#177; 1,3</td>
              <td align="center" valign="middle">0,60</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Plaquetas (103/uL)</td>
              <td align="center" valign="middle">311,4 &#177; 37</td>
              <td align="center" valign="middle">369,1 &#177; 38</td>
              <td align="center" valign="middle">0,25</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">FEVE (%)</td>
              <td align="center" valign="middle">53,4 &#177; 7,6</td>
              <td align="center" valign="middle">51,5 &#177; 8,1</td>
              <td align="center" valign="middle">0,18</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Di&#226;metro do &#225;trio esquerdo (mm)</td>
              <td align="center" valign="middle">44,2 &#177; 4,1</td>
              <td align="center" valign="middle">47,2 &#177; 5,2</td>
              <td align="center" valign="middle">0,09</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">LVSWT (mm)</td>
              <td align="center" valign="middle">10,3 &#177; 1,3</td>
              <td align="center" valign="middle">9,9 &#177; 2,1</td>
              <td align="center" valign="middle">0,51</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Peso bruto (mm)</td>
              <td align="center" valign="middle">9,2 &#177; 1,5</td>
              <td align="center" valign="middle">9,6 &#177; 1,8</td>
              <td align="center" valign="middle">0,89</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">DVEDF (mm)</td>
              <td align="center" valign="middle">48,9 &#177; 4,1</td>
              <td align="center" valign="middle">51,1 &#177; 3,9</td>
              <td align="center" valign="middle">0,13</td>
            </tr>
            <tr>
              <td align="left" valign="middle">DSVVE (mm)</td>
              <td align="center" valign="middle">33,9 &#177; 3,4</td>
              <td align="center" valign="middle">33,4 &#177; 3,5</td>
              <td align="center" valign="middle">0,57</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">ITCC</td>
              <td align="center" valign="middle">3413,3&#177;1232</td>
              <td align="center" valign="middle">1790,8 &#177; 689</td>
              <td align="center" valign="middle">&lt;0,001</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN1">
            <p>FAPO: fibrila&#231;&#227;o atrial p&#243;s-operat&#243;ria, IMC: &#237;ndice de massa corporal, Na: s&#243;dio, K: pot&#225;ssio, AST: aspartato aminotransferase, ALT: alanina aminotransferase, LDL-C: colesterol de lipoprote&#237;na de baixa densidade, PCR: prote&#237;na C-reativa, GB: gl&#243;bulo branco, FEVE: fra&#231;&#227;o de eje&#231;&#227;o do ventr&#237;culo esquerdo, LVSWT: espessura da parede septal do ventr&#237;culo esquerdo, PWT: espessura da parede posterior, LVEDD: di&#226;metro diast&#243;lico final do ventr&#237;culo esquerdo, LVESD: di&#226;metro sist&#243;lico final do ventr&#237;culo esquerdo, ITCC: triglicer&#237;deos, colesterol total e &#237;ndice de peso corporal.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>An&#225;lise de regress&#227;o de Cox univariada e multivariada foi realizada para identificar vari&#225;veis independentes que predizem FAPO. De acordo com an&#225;lises de regress&#227;o de Cox m&#250;ltiplas, idade e ITCC foram determinados como fortes preditores independentes de FAPO ap&#243;s a CRM (<xref ref-type="table" rid="t2">Tabela 2</xref>).</p>
      <table-wrap id="t2">
        <label>Tabela 2</label>
        <caption>
          <title>An&#225;lise de regress&#227;o de Cox univariada e multivariada para prever FAPO</title>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup width="20%">
            <col/>
            <col/>
            <col/>
            <col/>
            <col/>
          </colgroup>
          <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
            <tr style="background-color:#76B4D0;">
              <th align="left" valign="middle"/>
              <th align="center" colspan="2" style="border-bottom: thin solid; border-color: #000000" valign="middle">Univariada</th>
              <th align="center" colspan="2" style="border-bottom: thin solid; border-color: #000000" valign="middle">Multivariada</th>
            </tr>
            <tr style="background-color:#76B4D0;">
              <th align="left" valign="middle"/>
              <th align="center" valign="middle">Odds Ratio (IC 95%)</th>
              <th align="center" valign="middle">Valor p</th>
              <th align="center" valign="middle">Odds Ratio (IC 95%)</th>
              <th align="center" valign="middle">Valor p</th>
            </tr>
          </thead>
          <tbody style="border-bottom: thin solid; border-color: #000000">
            <tr>
              <td align="left" valign="middle">Idade</td>
              <td align="center" valign="middle">1.060 (1.029 &#8211; 1.091)</td>
              <td align="center" valign="middle">&lt;0,001</td>
              <td align="center" valign="middle">1.046 (1.014-1.080)</td>
              <td align="center" valign="middle">0,005</td>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">ITCC</td>
              <td align="center" valign="middle">0,997 (0,996 &#8211; 0,999)</td>
              <td align="center" valign="middle">&lt;0,001</td>
              <td align="center" valign="middle">0,998 (0,997-0,999)</td>
              <td align="center" valign="middle">&lt;0,001</td>
            </tr>
            <tr>
              <td align="left" valign="middle">Hipertens&#227;o</td>
              <td align="center" valign="middle">2.599 (1.241 &#8211; 5.445)</td>
              <td align="center" valign="middle">0,011</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle"/>
            </tr>
            <tr style="background-color:#C7DFEC;">
              <td align="left" valign="middle">PCR</td>
              <td align="center" valign="middle">1.007 (1.001 &#8211; 1.014)</td>
              <td align="center" valign="middle">0,024</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle"/>
            </tr>
            <tr>
              <td align="left" valign="middle">GB</td>
              <td align="center" valign="middle">1.091 (1.031 &#8211; 1.154)</td>
              <td align="center" valign="middle">0,003</td>
              <td align="center" valign="middle"/>
              <td align="center" valign="middle"/>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN2">
            <p>FAPO: fibrila&#231;&#227;o atrial p&#243;s-operat&#243;ria; ITCC: triglicer&#237;deos, colesterol total e &#237;ndice de peso corporal; PCR: prote&#237;na C-reativa; GB: gl&#243;bulos brancos.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Na an&#225;lise ROC, ITCC &lt; 1932,4 foi considerado um preditor de FAPO com sensibilidade de 75% e especificidade de 78% (<xref ref-type="fig" rid="f02">Figura 1</xref>).</p>
      <fig id="f02">
        <label>Figura 1</label>
        <caption>
          <title>Curva ROC do &#205;ndice de Triglicer&#237;deos-Colesterol-Peso Corporal (ITCC).</title>
        </caption>
        <graphic xlink:href="1678-4170-abc-122-04-e20240607-40607-gf01.tif"/></fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discuss&#227;o</title>
      <p>Este estudo abrangente investiga a rela&#231;&#227;o entre CRM e FAPO. O achado mais significativo do nosso estudo &#233; que o ITCC foi identificado como um preditor independente de FAPO.</p>
      <p>Historicamente, a FA n&#227;o era considerada uma complica&#231;&#227;o importante ap&#243;s cirurgia card&#237;aca. No entanto, estudos subsequentes demonstraram que a FAPO impacta significativamente tanto a mortalidade quanto a morbidade.<sup><xref ref-type="bibr" rid="B15">15</xref></sup> Por exemplo, um estudo conduzido com pacientes com CRM revelou que aqueles que desenvolveram FAPO experimentaram dura&#231;&#245;es mais longas em ventila&#231;&#227;o mec&#226;nica, bem como estadias prolongadas na unidade de terapia intensiva e no hospital.<sup><xref ref-type="bibr" rid="B16">16</xref></sup> Al&#233;m disso, a FAPO foi associada a um risco aumentado de mortalidade e acidente vascular cerebral em longo prazo.<sup><xref ref-type="bibr" rid="B17">17</xref></sup></p>
      <p>Em nosso estudo, se observou que pacientes com baixos n&#237;veis de ITCC apresentaram maior risco de FAPO no per&#237;odo p&#243;s-operat&#243;rio. Na literatura, o impacto do estado nutricional nos resultados cir&#250;rgicos tem sido frequentemente enfatizado, e tem sido demonstrado que a desnutri&#231;&#227;o retarda o processo de recupera&#231;&#227;o e aumenta o risco de complica&#231;&#245;es.<sup><xref ref-type="bibr" rid="B18">18</xref></sup> Dado o papel da inflama&#231;&#227;o no desenvolvimento da FA, acredita-se que o mau estado nutricional pode exacerbar esse processo. Foi demonstrado que a desnutri&#231;&#227;o aumenta eventos cardiovasculares e complica&#231;&#245;es ap&#243;s cirurgia cardiovascular.<sup><xref ref-type="bibr" rid="B19">19</xref></sup> O ITCC n&#227;o apenas prev&#234; complica&#231;&#245;es como FAPO, mas tamb&#233;m serve como um indicador sens&#237;vel do estado nutricional. Essa descoberta sugere que pacientes com mau estado nutricional podem exigir suporte nutricional mais intensivo durante o per&#237;odo pr&#233;-operat&#243;rio. Al&#233;m disso, nosso estudo confirma que, em compara&#231;&#227;o com outros indicadores nutricionais, o ITCC reflete mais especificamente a desnutri&#231;&#227;o e o risco de complica&#231;&#245;es. Uma melhor compreens&#227;o da rela&#231;&#227;o entre o estado nutricional e a FAPO pode contribuir para o desenvolvimento de abordagens nutricionais personalizadas nesses pacientes, reduzindo potencialmente as complica&#231;&#245;es p&#243;s-operat&#243;rias e melhorando os resultados gerais de sa&#250;de. Melhorar o estado nutricional tamb&#233;m pode aliviar a carga sobre os sistemas de sa&#250;de, reduzindo as complica&#231;&#245;es p&#243;s-operat&#243;rias a longo prazo.</p>
      <p>Dado o potencial da FAPO levar a complica&#231;&#245;es p&#243;s-operat&#243;rias s&#233;rias, identificar pacientes com alto risco de FA tornou-se uma meta cr&#237;tica. Esse entendimento levou os pesquisadores a conduzirem estudos mais abrangentes sobre os fatores de risco associados &#224; FAPO. &#201; bem sabido que o mau estado nutricional desencadeia inflama&#231;&#227;o, o que pode abrir caminho para complica&#231;&#245;es como FA ap&#243;s a cirurgia. &#205;ndices nutricionais como o ITCC s&#227;o considerados ferramentas importantes na previs&#227;o dessas complica&#231;&#245;es, e interven&#231;&#245;es nutricionais preventivas podem ser aplicadas, particularmente em pacientes de alto risco.</p>
      <p>V&#225;rios estudos destacaram fatores que podem contribuir para o desenvolvimento de FAPO. A hipoxemia foi identificada como um fator de risco significativo para FAPO,<sup><xref ref-type="bibr" rid="B20">20</xref></sup> enquanto outras pesquisas demonstraram uma correla&#231;&#227;o entre v&#225;rias t&#233;cnicas cir&#250;rgicas e a incid&#234;ncia de FAPO.<sup><xref ref-type="bibr" rid="B21">21</xref></sup> Fatores de risco como idade avan&#231;ada, aumento do di&#226;metro do &#225;trio esquerdo, fra&#231;&#227;o de eje&#231;&#227;o (FE) reduzida, doen&#231;a pulmonar obstrutiva cr&#244;nica (DPOC), hipertens&#227;o, infarto do mioc&#225;rdio e diabetes foram todos associados ao desenvolvimento de FAPO, conforme apoiado por uma meta-an&#225;lise envolvendo 36.834 pacientes.<sup><xref ref-type="bibr" rid="B22">22</xref></sup></p>
      <p>O valor do ITCC como um preditor significativo de resultados em v&#225;rias doen&#231;as, particularmente condi&#231;&#245;es cardiovasculares, tem sido cada vez mais reconhecido. Pesquisas t&#234;m mostrado que baixos n&#237;veis de ITCC est&#227;o fortemente associados &#224; mortalidade por todas as causas e mortalidade cardiovascular em pacientes com doen&#231;a arterial coronariana.<sup><xref ref-type="bibr" rid="B4">4</xref></sup> Al&#233;m disso, o ITCC &#233; recomendado para avaliar o estado nutricional de pacientes cardiovasculares, pois provou ser um forte preditor de mau progn&#243;stico e mortalidade em pacientes cardiovasculares e na popula&#231;&#227;o em geral.<sup><xref ref-type="bibr" rid="B4">4</xref></sup> Em nosso estudo, o ITCC foi considerado um preditor significativo de FA p&#243;s-operat&#243;ria em pacientes submetidos &#224; CRM.</p>
      <p>Os marcadores inflamat&#243;rios tamb&#233;m desempenham um papel significativo no desenvolvimento da FA. Muitos estudos mostraram que pacientes com FA tendem a ter n&#237;veis mais altos de marcadores inflamat&#243;rios em compara&#231;&#227;o com aqueles em RS.<sup><xref ref-type="bibr" rid="B23">23</xref></sup> Al&#233;m disso, os n&#237;veis de PCR demonstraram prever o desenvolvimento de FA de in&#237;cio recente.<sup><xref ref-type="bibr" rid="B24">24</xref></sup> Em nosso estudo, contagens elevadas de gl&#243;bulos brancos (GB) e n&#237;veis de PCR no grupo que desenvolveu FAPO sugerem que um mecanismo inflamat&#243;rio pode estar contribuindo para o in&#237;cio da FA.</p>
      <p>A idade tem sido consistentemente identificada como um fator de risco independente para o desenvolvimento de FA. Um estudo estimou que a preval&#234;ncia de FA em pacientes idosos na Uni&#227;o Europeia mais que dobraria ap&#243;s os 50 anos.<sup><xref ref-type="bibr" rid="B25">25</xref></sup> Nossas descobertas se alinham com essas observa&#231;&#245;es, pois identificamos a idade avan&#231;ada como um dos fatores de risco mais significativos para o desenvolvimento de FAPO.</p>
      <sec>
        <title>Limita&#231;&#245;es</title>
        <p>A limita&#231;&#227;o mais importante do estudo &#233; que ele &#233; retrospectivo. A falta de conhecimento suficiente sobre as t&#233;cnicas cir&#250;rgicas aplicadas tamb&#233;m &#233; uma limita&#231;&#227;o importante. Tamb&#233;m n&#227;o temos dados sobre os medicamentos anest&#233;sicos administrados aos pacientes antes da cirurgia. Os agentes anest&#233;sicos administrados tamb&#233;m podem ter alterado esse par&#226;metro. Estudos multic&#234;ntricos, prospectivos, randomizados e controlados s&#227;o necess&#225;rios para entender melhor se esse par&#226;metro &#233; preditivo de FAPO.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclus&#245;es</title>
      <p>O ITCC pode prever o desenvolvimento de FAPO em pacientes submetidos &#224; CRM. Com a ajuda deste par&#226;metro, os pacientes que precisam receber tratamento profil&#225;tico antes da CRM podem ser determinados, reduzindo assim a mortalidade e a morbidade.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="financial-disclosure" id="fn1">
        <label>Fontes de financiamento</label>
        <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
      </fn>
      <fn fn-type="other" id="fn2">
        <label>Vincula&#231;&#227;o acad&#234;mica</label>
        <p>N&#227;o h&#225; vincula&#231;&#227;o deste estudo a programas de p&#243;s-gradua&#231;&#227;o.</p>
      </fn>
      <fn fn-type="other" id="fn3">
        <label>Aprova&#231;&#227;o &#233;tica e consentimento informado</label>
        <p>Este estudo foi aprovado pelo Comit&#234; de &#201;tica do Bakircay University sob o n&#250;mero de protocolo 1918. Todos os procedimentos envolvidos nesse estudo est&#227;o de acordo com a Declara&#231;&#227;o de Helsinki de 1975, atualizada em 2013.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>Refer&#234;ncias</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dobrev</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Aguilar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Heijman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Guichard</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Nattel</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Postoperative Atrial Fibrillation: Mechanisms, Manifestations And Management</article-title>
          <source>Nat Rev Cardiol</source>
          <year>2019</year>
          <volume>16</volume>
          <issue>7</issue>
          <fpage>417</fpage>
          <lpage>436</lpage>
          <pub-id pub-id-type="doi">10.1038/s41569-019-0166-5</pub-id>
        </element-citation>
        <mixed-citation>1 Dobrev D, Aguilar M, Heijman J, Guichard JB, Nattel S. Postoperative Atrial Fibrillation: Mechanisms, Manifestations And Management. Nat Rev Cardiol. 2019;16(7):417-36. doi: 10.1038/s41569-019-0166-5.</mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burrage</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Low</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>New-Onset Atrial Fibrillation in Adult Patients after Cardiac Surgery</article-title>
          <source>Curr Anesthesiol Rep</source>
          <year>2019</year>
          <volume>9</volume>
          <issue>2</issue>
          <fpage>174</fpage>
          <lpage>193</lpage>
          <pub-id pub-id-type="doi">10.1007/s40140-019-00321-4</pub-id>
        </element-citation>
        <mixed-citation>2 Burrage PS, Low YH, Campbell NG, O'Brien B. New-Onset Atrial Fibrillation in Adult Patients after Cardiac Surgery. Curr Anesthesiol Rep. 2019;9(2):174-93. doi: 10.1007/s40140-019-00321-4.</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chermesh</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hajos</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mashiach</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bozhko</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shani</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Nir</surname>
              <given-names>RR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Malnutrition in Cardiac Surgery: Food for Thought</article-title>
          <source>Eur J Prev Cardiol</source>
          <year>2014</year>
          <volume>21</volume>
          <issue>4</issue>
          <fpage>475</fpage>
          <lpage>483</lpage>
          <pub-id pub-id-type="doi">10.1177/2047487312452969</pub-id>
        </element-citation>
        <mixed-citation>3 Chermesh I, Hajos J, Mashiach T, Bozhko M, Shani L, Nir RR, et al. Malnutrition in Cardiac Surgery: Food for Thought. Eur J Prev Cardiol. 2014;21(4):475-83. doi: 10.1177/2047487312452969.</mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maruyama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ebisawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Miura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yui</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kashiwagi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nagae</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impact of Nutritional &#304;ndex on Long-Term Outcomes of Elderly Patients with Coronary Artery Disease: Sub-Analysis of the SHINANO 5 Year Registry</article-title>
          <source>Heart Vessels</source>
          <year>2021</year>
          <volume>36</volume>
          <issue>1</issue>
          <fpage>7</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1007/s00380-020-01659-0</pub-id>
        </element-citation>
        <mixed-citation>4 Maruyama S, Ebisawa S, Miura T, Yui H, Kashiwagi D, Nagae A, et al. Impact of Nutritional &#304;ndex on Long-Term Outcomes of Elderly Patients with Coronary Artery Disease: Sub-Analysis of the SHINANO 5 Year Registry. Heart Vessels. 2021;36(1):7-13. doi: 10.1007/s00380-020-01659-0.</mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gudbjartsson</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Helgadottir</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sigurdsson</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Taha</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jeppsson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Christensen</surname>
              <given-names>TD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>New-Onset Postoperative Atrial Fibrillation after Heart Surgery</article-title>
          <source>Acta Anaesthesiol Scand</source>
          <year>2020</year>
          <volume>64</volume>
          <issue>2</issue>
          <fpage>145</fpage>
          <lpage>155</lpage>
          <pub-id pub-id-type="doi">10.1111/aas.13507</pub-id>
        </element-citation>
        <mixed-citation>5 Gudbjartsson T, Helgadottir S, Sigurdsson MI, Taha A, Jeppsson A, Christensen TD, et al. New-Onset Postoperative Atrial Fibrillation after Heart Surgery. Acta Anaesthesiol Scand. 2020;64(2):145-55. doi: 10.1111/aas.13507.</mixed-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Musa</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Dillon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Taib</surname>
              <given-names>MEM</given-names>
            </name>
            <name>
              <surname>Yunus</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Sanusi</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Nordin</surname>
              <given-names>MN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Incidence and Outcomes of Postoperative Atrial Fibrillation after Coronary Artery Bypass Grafting of a Randomized Controlled Trial: A Blinded End-of-Cycle Analysis</article-title>
          <source>Rev Cardiovasc Med</source>
          <year>2022</year>
          <volume>23</volume>
          <issue>4</issue>
          <fpage>122</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="doi">10.31083/j.rcm2304122</pub-id>
        </element-citation>
        <mixed-citation>6 Musa AF, Dillon J, Taib MEM, Yunus AM, Sanusi AR, Nordin MN, et al. Incidence and Outcomes of Postoperative Atrial Fibrillation after Coronary Artery Bypass Grafting of a Randomized Controlled Trial: A Blinded End-of-Cycle Analysis. Rev Cardiovasc Med. 2022;23(4):122. doi: 10.31083/j.rcm2304122.</mixed-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ahlsson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fengsrud</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bodin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Englund</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Postoperative Atrial Fibrillation in Patients Undergoing Aortocoronary Bypass Surgery Carries an Eightfold Risk of Future Atrial Fibrillation and a Doubled Cardiovascular Mortality</article-title>
          <source>Eur J Cardiothorac Surg</source>
          <year>2010</year>
          <volume>37</volume>
          <issue>6</issue>
          <fpage>1353</fpage>
          <lpage>1359</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejcts.2009.12.033</pub-id>
        </element-citation>
        <mixed-citation>7 Ahlsson A, Fengsrud E, Bodin L, Englund A. Postoperative Atrial Fibrillation in Patients Undergoing Aortocoronary Bypass Surgery Carries an Eightfold Risk of Future Atrial Fibrillation and a Doubled Cardiovascular Mortality. Eur J Cardiothorac Surg. 2010;37(6):1353-9. doi: 10.1016/j.ejcts.2009.12.033.</mixed-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oraii</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Masoudkabir</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pashang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jalali</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sadeghian</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mortazavi</surname>
              <given-names>SH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of Postoperative Atrial Fibrillation on Early and Mid-Term Outcomes of Coronary Artery Bypass Graft Surgery</article-title>
          <source>Eur J Cardiothorac Surg</source>
          <year>2022</year>
          <volume>62</volume>
          <issue>3</issue>
          <comment>ezac264</comment>
          <pub-id pub-id-type="doi">10.1093/ejcts/ezac264</pub-id>
        </element-citation>
        <mixed-citation>8 Oraii A, Masoudkabir F, Pashang M, Jalali A, Sadeghian S, Mortazavi SH, et al. Effect of Postoperative Atrial Fibrillation on Early and Mid-Term Outcomes of Coronary Artery Bypass Graft Surgery. Eur J Cardiothorac Surg. 2022;62(3):ezac264. doi: 10.1093/ejcts/ezac264.</mixed-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Uhm</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Shim</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>New-Onset Atrial Fibrillation Predicts Long-Term Newly Developed Atrial Fibrillation after Coronary Artery Bypass Graft</article-title>
          <source>Am Heart J</source>
          <year>2014</year>
          <volume>167</volume>
          <issue>4</issue>
          <fpage>593.e1</fpage>
          <lpage>600.e1</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ahj.2013.12.010</pub-id>
        </element-citation>
        <mixed-citation>9 Lee SH, Kang DR, Uhm JS, Shim J, Sung JH, Kim JY, et al. New-Onset Atrial Fibrillation Predicts Long-Term Newly Developed Atrial Fibrillation after Coronary Artery Bypass Graft. Am Heart J. 2014;167(4):593-600.e1. doi: 10.1016/j.ahj.2013.12.010.</mixed-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ishiwata</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yatsu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kasai</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shitara</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prognostic Effect of a Novel Simply Calculated Nutritional Index in Acute Decompensated Heart Failure</article-title>
          <source>Nutrients</source>
          <year>2020</year>
          <volume>12</volume>
          <issue>11</issue>
          <fpage>3311</fpage>
          <lpage>3311</lpage>
          <pub-id pub-id-type="doi">10.3390/nu12113311</pub-id>
        </element-citation>
        <mixed-citation>10 Ishiwata S, Yatsu S, Kasai T, Sato A, Matsumoto H, Shitara J, et al. Prognostic Effect of a Novel Simply Calculated Nutritional Index in Acute Decompensated Heart Failure. Nutrients. 2020;12(11):3311. doi: 10.3390/nu12113311.</mixed-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minami-Takano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Iwata</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Miyosawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kubota</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Osawa</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A Novel Nutritional Index Serves as A Useful Prognostic Indicator in Cardiac Critical Patients Requiring Mechanical Circulatory Support</article-title>
          <source>Nutrients</source>
          <year>2019</year>
          <volume>11</volume>
          <issue>6</issue>
          <fpage>1420</fpage>
          <lpage>1420</lpage>
          <pub-id pub-id-type="doi">10.3390/nu11061420</pub-id>
        </element-citation>
        <mixed-citation>11 Minami-Takano A, Iwata H, Miyosawa K, Kubota K, Kimura A, Osawa S, et al. A Novel Nutritional Index Serves as A Useful Prognostic Indicator in Cardiac Critical Patients Requiring Mechanical Circulatory Support. Nutrients. 2019;11(6):1420. doi: 10.3390/nu11061420.</mixed-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fan</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Association of Four Nutritional Scores With All-Cause and Cardiovascular Mortality in the General Population</article-title>
          <source>Front Nutr</source>
          <year>2022</year>
          <volume>9</volume>
          <fpage>846659</fpage>
          <lpage>846659</lpage>
          <pub-id pub-id-type="doi">10.3389/fnut.2022.846659</pub-id>
        </element-citation>
        <mixed-citation>12 Fan H, Huang Y, Zhang H, Feng X, Yuan Z, Zhou J. Association of Four Nutritional Scores With All-Cause and Cardiovascular Mortality in the General Population. Front Nutr. 2022;9:846659. doi: 10.3389/fnut.2022.846659.</mixed-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Association of a Novel Nutritional &#304;ndex with Stroke in Chinese Population with Hypertension: Insight from the China H-type Hypertension Registry Study</article-title>
          <source>Front Nutr</source>
          <year>2023</year>
          <volume>10</volume>
          <fpage>997180</fpage>
          <lpage>997180</lpage>
          <pub-id pub-id-type="doi">10.3389/fnut.2023.997180</pub-id>
        </element-citation>
        <mixed-citation>13 Shi Y, Wang X, Yu C, Zhou W, Wang T, Zhu L, et al. Association of a Novel Nutritional &#304;ndex with Stroke in Chinese Population with Hypertension: Insight from the China H-type Hypertension Registry Study. Front Nutr. 2023;10:997180. doi: 10.3389/fnut.2023.997180.</mixed-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Lobato</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Pinesett</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Maxwell</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Mora-Mangano</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>MV</given-names>
            </name>
          </person-group>
          <article-title>P-Wave Characteristics on Routine Preoperative Electrocardiogram &#304;mprove Prediction of New-Onset Postoperative Atrial Fibrillation in Cardiac Surgery</article-title>
          <source>J Cardiothorac Vasc Anesth</source>
          <year>2014</year>
          <volume>28</volume>
          <issue>6</issue>
          <fpage>1497</fpage>
          <lpage>1504</lpage>
          <pub-id pub-id-type="doi">10.1053/j.jvca.2014.04.034</pub-id>
        </element-citation>
        <mixed-citation>14 Wong JK, Lobato RL, Pinesett A, Maxwell BG, Mora-Mangano CT, Perez MV. P-Wave Characteristics on Routine Preoperative Electrocardiogram &#304;mprove Prediction of New-Onset Postoperative Atrial Fibrillation in Cardiac Surgery. J Cardiothorac Vasc Anesth. 2014;28(6):1497-504. doi: 10.1053/j.jvca.2014.04.034.</mixed-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stamou</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Dangas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Pfister</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Dullum</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Boyce</surname>
              <given-names>SW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Atrial Fibrillation after Beating Heart Surgery</article-title>
          <source>Am J Cardiol</source>
          <year>2000</year>
          <volume>86</volume>
          <issue>1</issue>
          <fpage>64</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="doi">10.1016/s0002-9149(00)00829-8</pub-id>
        </element-citation>
        <mixed-citation>15 Stamou SC, Dangas G, Hill PC, Pfister AJ, Dullum MK, Boyce SW, et al. Atrial Fibrillation after Beating Heart Surgery. Am J Cardiol. 2000;86(1):64-7. doi: 10.1016/s0002-9149(00)00829-8.</mixed-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghurram</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Krishna</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Bhaskaran</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kumaraswamy</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Jayant</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Varma</surname>
              <given-names>PK</given-names>
            </name>
          </person-group>
          <article-title>Patients Who Develop Post-Operative Atrial Fibrillation have Reduced Survival after Off-Pump Coronary Artery Bypass Grafting</article-title>
          <source>Indian J Thorac Cardiovasc Surg</source>
          <year>2020</year>
          <volume>36</volume>
          <issue>1</issue>
          <fpage>6</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1007/s12055-019-00844-9</pub-id>
        </element-citation>
        <mixed-citation>16 Ghurram A, Krishna N, Bhaskaran R, Kumaraswamy N, Jayant A, Varma PK. Patients Who Develop Post-Operative Atrial Fibrillation have Reduced Survival after Off-Pump Coronary Artery Bypass Grafting. Indian J Thorac Cardiovasc Surg. 2020;36(1):6-13. doi: 10.1007/s12055-019-00844-9.</mixed-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kosmidou</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>New-Onset Atrial Fibrillation after PCI and CABG for Left Main Disease: &#304;nsights from the EXCEL Trial and Additional Studies</article-title>
          <source>Curr Opin Cardiol</source>
          <year>2018</year>
          <month>11</month>
          <volume>33</volume>
          <issue>6</issue>
          <fpage>660</fpage>
          <lpage>664</lpage>
          <pub-id pub-id-type="doi">10.1097/HCO.0000000000000557</pub-id>
        </element-citation>
        <mixed-citation>17 Kosmidou I, Stone GW. New-Onset Atrial Fibrillation after PCI and CABG for Left Main Disease: &#304;nsights from the EXCEL Trial and Additional Studies. Curr Opin Cardiol. 2018 Nov;33(6):660-4. doi: 10.1097/HCO.0000000000000557.</mixed-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopez-Delgado</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Mu&#241;oz-Del Rio</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Flordel&#237;s-Lasierra</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Putzu</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Nutrition in Adult Cardiac Surgery: Preoperative Evaluation, Management in the Postoperative Period, and Clinical Implications for Outcomes</article-title>
          <source>J Cardiothorac Vasc Anesth</source>
          <year>2019</year>
          <month>11</month>
          <volume>33</volume>
          <issue>11</issue>
          <fpage>3143</fpage>
          <lpage>3162</lpage>
          <pub-id pub-id-type="doi">10.1053/j.jvca.2019.04.002</pub-id>
          <comment>Epub 2019 Apr 19</comment>
          <pub-id pub-id-type="pmid">31101509</pub-id>
        </element-citation>
        <mixed-citation>18 Lopez-Delgado JC, Mu&#241;oz-Del Rio G, Flordel&#237;s-Lasierra JL, Putzu A. Nutrition in Adult Cardiac Surgery: Preoperative Evaluation, Management in the Postoperative Period, and Clinical Implications for Outcomes. J Cardiothorac Vasc Anesth. 2019 Nov;33(11):3143-3162. doi: 10.1053/j.jvca.2019.04.002. Epub 2019 Apr 19. PMID: 31101509.</mixed-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yildiz</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Bayir</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Malnutrition and Adverse Effects in Cardiac Surgery</article-title>
          <source>Thorac Cardiovasc Surg</source>
          <year>2015</year>
          <volume>63</volume>
          <fpage>349</fpage>
          <lpage>350</lpage>
        </element-citation>
        <mixed-citation>19 Yildiz I, Bayir H. Malnutrition and Adverse Effects in Cardiac Surgery. Thorac Cardiovasc Surg. 2015; 63: 349-350.</mixed-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wahr</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Parks</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Boisvert</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Comunale</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fabian</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ramsay</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Preoperative Serum Potassium Levels and Perioperative Outcomes in Cardiac Surgery Patients. Multicenter Study of Perioperative Ischemia Research Group</article-title>
          <source>JAMA</source>
          <year>1999</year>
          <volume>281</volume>
          <issue>23</issue>
          <fpage>2203</fpage>
          <lpage>2210</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.281.23.2203</pub-id>
        </element-citation>
        <mixed-citation>20 Wahr JA, Parks R, Boisvert D, Comunale M, Fabian J, Ramsay J, et al. Preoperative Serum Potassium Levels and Perioperative Outcomes in Cardiac Surgery Patients. Multicenter Study of Perioperative Ischemia Research Group. JAMA. 1999;281(23):2203-10. doi: 10.1001/jama.281.23.2203.</mixed-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaman</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Archbold</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Helft</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Paul</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Curzen</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>Mills</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>
          <article-title>Atrial Fibrillation after Coronary Artery Bypass Surgery: A Model for Preoperative Risk Stratification</article-title>
          <source>Circulation</source>
          <year>2000</year>
          <volume>101</volume>
          <issue>12</issue>
          <fpage>1403</fpage>
          <lpage>1408</lpage>
          <pub-id pub-id-type="doi">10.1161/01.cir.101.12.1403</pub-id>
        </element-citation>
        <mixed-citation>21 Zaman AG, Archbold RA, Helft G, Paul EA, Curzen NP, Mills PG. Atrial Fibrillation after Coronary Artery Bypass Surgery: A Model for Preoperative Risk Stratification. Circulation. 2000;101(12):1403-8. doi: 10.1161/01.cir.101.12.1403.</mixed-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamashita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ranjan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Selzman</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Dosdall</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Clinical Risk Factors for Postoperative Atrial Fibrillation among Patients after Cardiac Surgery</article-title>
          <source>Thorac Cardiovasc Surg</source>
          <year>2019</year>
          <volume>67</volume>
          <issue>2</issue>
          <fpage>107</fpage>
          <lpage>116</lpage>
          <pub-id pub-id-type="doi">10.1055/s-0038-1667065</pub-id>
        </element-citation>
        <mixed-citation>22 Yamashita K, Hu N, Ranjan R, Selzman CH, Dosdall DJ. Clinical Risk Factors for Postoperative Atrial Fibrillation among Patients after Cardiac Surgery. Thorac Cardiovasc Surg. 2019;67(2):107-16. doi: 10.1055/s-0038-1667065.</mixed-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smit</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Maass</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>De Jong</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Kobold</surname>
              <given-names>ACM</given-names>
            </name>
            <name>
              <surname>Van Veldhuisen</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Van Gelder</surname>
              <given-names>IC</given-names>
            </name>
          </person-group>
          <article-title>Role of &#304;nflammation in Early Atrial Fibrillation Recurrence</article-title>
          <source>Europace</source>
          <year>2012</year>
          <volume>14</volume>
          <issue>6</issue>
          <fpage>810</fpage>
          <lpage>817</lpage>
          <pub-id pub-id-type="doi">10.1093/europace/eur402</pub-id>
        </element-citation>
        <mixed-citation>23 Smit MD, Maass AH, De Jong AM, Kobold ACM, Van Veldhuisen DJ, Van Gelder IC. Role of &#304;nflammation in Early Atrial Fibrillation Recurrence. Europace. 2012;14(6):810-7. doi: 10.1093/europace/eur402.</mixed-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aviles</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>DO</given-names>
            </name>
            <name>
              <surname>Apperson-Hansen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Houghtaling</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Rautaharju</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kronmal</surname>
              <given-names>RA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Inflammation as a Risk Factor for Atrial Fibrillation</article-title>
          <source>Circulation</source>
          <year>2003</year>
          <volume>108</volume>
          <issue>24</issue>
          <fpage>3006</fpage>
          <lpage>3010</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.0000103131.70301.4F</pub-id>
        </element-citation>
        <mixed-citation>24 Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a Risk Factor for Atrial Fibrillation. Circulation. 2003;108(24):3006-10. doi: 10.1161/01.CIR.0000103131.70301.4F.</mixed-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zathar</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Karunatilleke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fawzy</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Lip</surname>
              <given-names>GYH</given-names>
            </name>
          </person-group>
          <article-title>Atrial Fibrillation in Older People: Concepts and Controversies</article-title>
          <source>Front Med</source>
          <year>2019</year>
          <volume>6</volume>
          <fpage>175</fpage>
          <lpage>175</lpage>
          <pub-id pub-id-type="doi">10.3389/fmed.2019.00175</pub-id>
        </element-citation>
        <mixed-citation>25 Zathar Z, Karunatilleke A, Fawzy AM, Lip GYH. Atrial Fibrillation in Older People: Concepts and Controversies. Front Med. 2019;6:175. doi: 10.3389/fmed.2019.00175.</mixed-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="S1" xml:lang="en">
    <front-stub>
      <article-id pub-id-type="doi">10.36660/abc.20240607i</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Parameter Predicting Postoperative Atrial Fibrillation in Coronary Artery Bypass Grafting Patients: Triglyceride-Cholesterol-Body Weight Index</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-7594-0203</contrib-id>
          <name>
            <surname>Koyuncu</surname>
            <given-names>&#304;lhan</given-names>
          </name>
          <role>Conception and design of the research and Writing of the manuscript</role>
          <role>Acquisition of data</role>
          <role>Analysis and interpretation of the data</role>
          <role>Statistical analysis and Critical revision of the manuscript for content</role>
          <xref ref-type="aff" rid="aff3">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="c2"/>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-9823-1613</contrib-id>
          <name>
            <surname>Koyun</surname>
            <given-names>Emin</given-names>
          </name>
          <role>Acquisition of data</role>
          <role>Analysis and interpretation of the data</role>
          <role>Statistical analysis and Critical revision of the manuscript for content</role>
          <xref ref-type="aff" rid="aff4">
            <sup>2</sup>
          </xref>
        </contrib>
        <aff id="aff3">
          <label>1</label>
          <addr-line>
            <named-content content-type="city">&#304;zmir</named-content>
          </addr-line>
          <country country="TR">T&#252;rkiye</country>
          <institution content-type="original">Department of Cardiology, Bakircay University, Cigli Training and Research Hospital, &#304;zmir - T&#252;rkiye</institution>
        </aff>
        <aff id="aff4">
          <label>2</label>
          <addr-line>
            <named-content content-type="city">Sivas</named-content>
          </addr-line>
          <country country="TR">T&#252;rkiye</country>
          <institution content-type="original">Department of Cardiology, Sivas Numune Hospital, Sivas - T&#252;rkiye</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c2"><label>Mailing Address:</label><bold>&#304;lhan Koyuncu</bold> &#8226; Bakircay University, Cigli Training and Research Hospital - Yeni Mahalle, 8780/1. Sk. No:18, <postal-code>35620</postal-code> &#199;i&#287;li, &#304;zmir &#8211; T&#252;rkiye E-mail: <email>dr_ilhann@hotmail.com</email> </corresp>
        <fn fn-type="conflict">
          <label>Potential conflict of interest</label>
          <p>No potential conflict of interest relevant to this article was reported.</p>
        </fn>
        <fn fn-type="edited-by">
          <label>Editor responsible for the review:</label>
          <p>Alexandre Colafranceschi</p>
        </fn>
      </author-notes>
      <abstract>
        <title>Abstract</title>
        <sec>
          <title>Background:</title>
          <p>Postoperative atrial fibrillation (POAF) is a common complication after cardiac surgery, particularly coronary artery bypass grafting (CABG). Despite advances in surgical techniques, POAF remains a significant cause of morbidity and mortality.</p>
        </sec>
        <sec>
          <title>Objectives:</title>
          <p>This study investigates the potential of the Triglyceride-Cholesterol-Body weight Index (TCBI) as a predictor of POAF, focusing on the impact of nutritional status on surgical outcomes.</p>
        </sec>
        <sec>
          <title>Methods:</title>
          <p>This retrospective study included 321 patients who underwent CABG surgery between January 2010 and January 2024. TCBI was calculated using preoperative blood samples and compared between those who developed POAF and those who did not. Statistical analyses, including Cox regression and ROC analysis, were performed to assess the predictive value of TCBI for POAF. P&lt;0.05 was considered statistically significant.</p>
        </sec>
        <sec>
          <title>Results:</title>
          <p>Patients who developed POAF had significantly lower TCBI (1790.8 &#177; 689, 3413.3&#177;1232, p&lt;0.001, respectively) levels compared to those without POAF. Also, age (p&lt;0.001), the frequency of hypertension (p=0.009), CRP (p=0.03), and WBC (p=0.02) values were also significantly higher in patients who developed POAF.TCBI was identified as an independent predictor of POAF (OR: 0.998, 95% CI: 0.997-0.999, p&lt;0.001), with a cut-off value of 1932.4 predicting POAF with 75% sensitivity and 78% specificity.</p>
        </sec>
        <sec>
          <title>Conclusion:</title>
          <p>The TCBI is a reliable indicator for predicting POAF in CABG patients. Preoperative identification of patients with low TCBI could lead to targeted interventions, reducing postoperative complications and improving outcomes. Optimizing nutritional status before surgery may mitigate the risk of POAF.</p>
        </sec>
      </abstract>
      <abstract abstract-type="graphical">
        <p>
          <fig id="f01001">
            <label>Central Illustration</label>
            <caption>
              <title>: Parameter Predicting Postoperative Atrial Fibrillation in Coronary Artery Bypass Grafting Patients: Triglyceride-Cholesterol-Body Weight Index</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-122-04-e20240607-40607-gf01-en.tif"/></fig>
        </p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords:</title>
        <kwd>Postoperative Atrial Fibrillation</kwd>
        <kwd>Triglyceride-Cholesterol-Body Weight Index</kwd>
        <kwd>Coronary Artery Bypass Grafting</kwd>
        <kwd>Nutrition</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec sec-type="intro">
        <title>Introduction</title>
        <p>Atrial fibrillation (AF) is one of the common complications following cardiac surgery and remains the most prevalent type of arrhythmia after surgery. Postoperative atrial fibrillation (POAF) is defined as AF that develops within 1 to 5 days after cardiac surgery in patients without a prior diagnosis of AF. Fortunately, POAF often converts to sinus rhythm (SR) spontaneously within the first 24 hours.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> Studies have found that POAF develops in 25% to 50% of patients depending on the type of surgical procedure.<sup><xref ref-type="bibr" rid="B2">2</xref></sup></p>
        <p>The effect of nutritional status on cardiovascular surgery outcomes has long been recognized. Inadequate nutrition increases the risk of postoperative complications by improving processes such as inflammation and oxidative stress. Particularly in major surgical interventions like coronary artery bypass graft (CABG), good nutritional status in the preoperative period can accelerate postoperative recovery and reduce mortality.<sup><xref ref-type="bibr" rid="B3">3</xref></sup> Simple and accessible nutritional indicators such as triglyceride-cholesterol-body weight Index (TCBI) are important tools for evaluating nutritional status in the preoperative period. Low TCBI levels are considered a sign of malnutrition and have been shown to be effective in predicting cardiovascular events in coronary artery disease patients.<sup><xref ref-type="bibr" rid="B4">4</xref></sup> Therefore, optimizing nutritional support before major surgeries like CABG is crucial for reducing postoperative complications. Inadequate nutrition not only increases the risk of postoperative complications but also negatively affects overall quality of life and long-term survival. Indicators such as TCBI are valuable tools for predicting these risks and applying preventive nutritional interventions. In this context, accurately assessing patients' nutritional status before surgery is a critical step to prevent complications.</p>
        <p>Despite advancements in surgical techniques and perioperative treatments, the incidence of POAF has not decreased over time. POAF continues to contribute to increased postoperative morbidity and mortality.<sup><xref ref-type="bibr" rid="B5">5</xref></sup> Moreover, it remains a significant factor in healthcare costs.<sup><xref ref-type="bibr" rid="B6">6</xref></sup> Notably, AF is observed more frequently in patients with POAF compared to those in postoperative SR.<sup><xref ref-type="bibr" rid="B7">7</xref></sup></p>
        <p>Several studies have demonstrated that POAF is associated with an increased incidence of short-term complications, particularly after coronary artery bypass graft (CABG) surgery.<sup><xref ref-type="bibr" rid="B8">8</xref></sup> Furthermore, long-term studies have shown that POAF is linked with an increased risk of death and thromboembolic complications.<sup><xref ref-type="bibr" rid="B9">9</xref></sup></p>
        <p>In recent years, research has focused on biochemical and metabolic markers that may predict POAF, especially as preventive strategies could mitigate associated risks. One such marker is the TCBI, calculated as:</p>
        <disp-formula id="eq2">
          <mml:math display="block" id="m02">
            <mml:mrow>
              <mml:mtext>TCBI</mml:mtext>
              <mml:mo>=</mml:mo>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mtext>Triglyceride(mg/dL)</mml:mtext>
                  <mml:mo>&#215;</mml:mo>
                  <mml:mtext>Total cholesterol(mg/dL)</mml:mtext>
                  <mml:mo>&#215;</mml:mo>
                  <mml:mtext>Body weight(kg)</mml:mtext>
                </mml:mrow>
                <mml:mrow>
                  <mml:mn>1</mml:mn>
                  <mml:mo>,</mml:mo>
                  <mml:mn>000</mml:mn>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
          </mml:math>
        </disp-formula>
        <p>Previous studies have shown that TCBI is a critical marker in patients with heart failure,<sup><xref ref-type="bibr" rid="B10">10</xref></sup> coronary artery disease,<sup><xref ref-type="bibr" rid="B4">4</xref></sup> critical illness,<sup><xref ref-type="bibr" rid="B11">11</xref></sup> as well as in the general population and stroke patients.<sup><xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref></sup> However, the relationship between TCBI and AF, particularly POAF, remains unexplored. Inadequate nutritional status not only increases the risk of postoperative complications but also negatively affects overall quality of life and long-term survival. Indicators such as TCBI are valuable tools for predicting these risks and applying preventive nutritional interventions. Therefore, accurately assessing patients' nutritional status before surgery is a critical step in preventing complications.</p>
      </sec>
      <sec>
        <title>Objective of the study</title>
        <p>This study aims to investigate the relationship between TCBI and POAF by calculating TCBI from blood samples taken before CABG surgery. If a significant association is found, it may be possible to identify high-risk patients preoperatively and monitor them closely post-surgery. This could lead to reduced morbidity and mortality in patients prone to developing POAF, offering a new avenue for preventive care based on nutritional and metabolic risk factors.</p>
      </sec>
      <sec sec-type="methods">
        <title>Methods</title>
        <sec>
          <title>Patient population and defining of TCBI</title>
          <p>Our study was designed retrospectively. Between January 2010 and January 2024, 321 consecutive patients who underwent CABG surgery in our center were included in the study. The study design and flowchart are shown in the <xref ref-type="fig" rid="f01001">Central Illustration</xref>. The patient's files were evaluated retrospectively. The electrocardiograms (ECG) of the patients included in the study taken before CABG surgery were in SR. The patients were divided into two groups: those who developed postoperative AF and those who did not. Demographic characteristics, TCBI, and blood parameters of both groups were compared. The TCBI was calculated with this formula: &#8216;Triglycerides x Total cholesterol x Body weight/1,000'. The local ethics committee approved the present study. Our study was carried out in compliance with the ethical guidelines of the Declaration of Helsinki.</p>
          <p>Criteria for inclusion in the study: these were defined as having no previous diagnosis of AF, undergoing CABG surgery, and having a documented sinus ECG before surgery.</p>
          <p>Exclusion criteria: patients with electrolyte disorders, patients with severe heart valve diseases and chronic renal failure, patients with pacemakers, patients using antiarrhythmic drugs, patients with metabolic disorders, and patients without a preoperative SR ECG.</p>
          <p>The definition of POAF was made as follows: in 5 days after cardiac surgery, arrhythmia lasting more than 10 minutes resolved spontaneously or was treated with electrical/medical cardioversion.<sup><xref ref-type="bibr" rid="B14">14</xref></sup> Patients were closely monitored for arrhythmia throughout their hospital stay. An ECG was also taken when cardiac symptoms such as palpitations occurred. ECGs of the patients were recorded in 12 leads at 10 mm/mV and 25 mm/s settings.</p>
        </sec>
        <sec>
          <title>Statistical analysis</title>
          <p>Histogram, q-q graph, and Shapiro-Wilk test were used to evaluate whether the data violated normality assumptions. A two-sample T-test was performed to compare continuous variables between groups. Chi-square analysis was used to evaluate the relationship between categorical variables. The continuous data were presented as mean &#177; standard deviation (SD) based on the data distribution. The categorical variables were expressed as the number (n) with a percentage (%). Cox regression analysis was used to determine the risk factors affecting POAF status. Variables that were found to be statistically significant as a result of Cox regression analysis were evaluated with univariate and multivariate Cox regression analysis. ROC (Receiver operating characteristic) analysis was performed to evaluate TCBI index and age in predicting POAF. The area under the curve and the cut-off value were calculated for each parameter value. Sensitivity and specificity were calculated to determine the diagnostic power of the scores. It was accepted that p-values should be &lt;0.05 for the parameters to be statistically significant. Analysis of the data was performed in SPSS 22 statistical software.</p>
        </sec>
      </sec>
      <sec sec-type="results">
        <title>Results</title>
        <p>Among the 321 patients included in the study, the number of patients who developed POAF after CABG was found to be 62. When the baseline clinical and demographic characteristics of both groups were compared, the age of the patients in the POAF group was higher than the other group. The number of hypertension was also higher in the POAF group than in the other group. CRP value was also found to be higher in the POAF group compared to the other group. WBC value was also found to be higher in the POAF group. Additionally, the TCBI was found to be lower in the POAF group than in the other group. There was no significant difference between the groups except in age, hypertension, CRP, WBC, and TCBI (<xref ref-type="table" rid="t3">Table 1</xref>).</p>
        <table-wrap id="t3">
          <label>Table 1</label>
          <caption>
            <title>Comparison of baseline clinical, demographic, and laboratory characteristics between groups</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup width="25%">
              <col/>
              <col/>
              <col/>
              <col/>
            </colgroup>
            <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
              <tr style="background-color:#76B4D0;">
                <th align="left" valign="middle"/>
                <th align="center" valign="middle">POAF (-) group<break/>(n = 259)</th>
                <th align="center" valign="middle">POAF (+) group<break/>(n = 62)</th>
                <th align="center" valign="middle">p Value</th>
              </tr>
            </thead>
            <tbody style="border-bottom: thin solid; border-color: #000000">
              <tr>
                <td align="left" valign="middle">Age, years</td>
                <td align="center" valign="middle">61.96 &#177; 9.3</td>
                <td align="center" valign="middle">67.09 &#177; 6.5</td>
                <td align="center" valign="middle">&lt;0.001</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">Female gender, n (%)</td>
                <td align="center" valign="middle">65 (25.1)</td>
                <td align="center" valign="middle">16 (25.8)</td>
                <td align="center" valign="middle">0.08</td>
              </tr>
              <tr>
                <td align="left" valign="middle">Length (cm)</td>
                <td align="center" valign="middle">170&#177;7.1</td>
                <td align="center" valign="middle">169.3&#177;7.3</td>
                <td align="center" valign="middle">0.72</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">Body weight (kg)</td>
                <td align="center" valign="middle">75.2&#177;11.1</td>
                <td align="center" valign="middle">77.6&#177;10.6</td>
                <td align="center" valign="middle">0.45</td>
              </tr>
              <tr>
                <td align="left" valign="middle">BMI (kg/m<sup>2</sup>)</td>
                <td align="center" valign="middle">26.80 &#177; 3.25</td>
                <td align="center" valign="middle">27.41 &#177; 3.36</td>
                <td align="center" valign="middle">0.67</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">Hypertension, n (%)</td>
                <td align="center" valign="middle">190 (73.3)</td>
                <td align="center" valign="middle">55 (88)</td>
                <td align="center" valign="middle">0.009</td>
              </tr>
              <tr>
                <td align="left" valign="middle">Diabetes Mellitus, n (%)</td>
                <td align="center" valign="middle">120 (46.3)</td>
                <td align="center" valign="middle">26 (41.9)</td>
                <td align="center" valign="middle">0.35</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">Hyperlipidemia, n (%)</td>
                <td align="center" valign="middle">230 (88.8)</td>
                <td align="center" valign="middle">55 (88.7)</td>
                <td align="center" valign="middle">0.81</td>
              </tr>
              <tr>
                <td align="left" valign="middle">Smoking, n (%)</td>
                <td align="center" valign="middle">121 (46.7)</td>
                <td align="center" valign="middle">22 (35.4)</td>
                <td align="center" valign="middle">0.08</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">Systolic BP (mmHg)</td>
                <td align="center" valign="middle">136.6 &#177; 12.8</td>
                <td align="center" valign="middle">139.1 &#177; 16.5</td>
                <td align="center" valign="middle">0.10</td>
              </tr>
              <tr>
                <td align="left" valign="middle">Diastolic BP (mmHg)</td>
                <td align="center" valign="middle">78.1 &#177; 8.3</td>
                <td align="center" valign="middle">79.3 &#177; 7.5</td>
                <td align="center" valign="middle">0.25</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">Creatinin (mg/dl)</td>
                <td align="center" valign="middle">0.9 &#177; 0.1</td>
                <td align="center" valign="middle">0.8 &#177; 0.15</td>
                <td align="center" valign="middle">0.17</td>
              </tr>
              <tr>
                <td align="left" valign="middle">Na (mmol/L)</td>
                <td align="center" valign="middle">138.7 &#177; 3.1</td>
                <td align="center" valign="middle">137.1 &#177; 2.2</td>
                <td align="center" valign="middle">0.90</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">K (mmol/L)</td>
                <td align="center" valign="middle">4.2 &#177; 0.2</td>
                <td align="center" valign="middle">4.3 &#177; 0.4</td>
                <td align="center" valign="middle">0.30</td>
              </tr>
              <tr>
                <td align="left" valign="middle">AST (U/L)</td>
                <td align="center" valign="middle">34 &#177;5.8</td>
                <td align="center" valign="middle">36&#177;7.3</td>
                <td align="center" valign="middle">0.50</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">ALT (U/L)</td>
                <td align="center" valign="middle">31 &#177;6.6</td>
                <td align="center" valign="middle">36&#177;9.2</td>
                <td align="center" valign="middle">0.51</td>
              </tr>
              <tr>
                <td align="left" valign="middle">Total cholesterol</td>
                <td align="center" valign="middle">234.3 &#177; 14.5</td>
                <td align="center" valign="middle">221.5 &#177; 15.1</td>
                <td align="center" valign="middle">0.60</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">LDL-C</td>
                <td align="center" valign="middle">146.5 &#177; 9.2</td>
                <td align="center" valign="middle">159.1 &#177; 9.6</td>
                <td align="center" valign="middle">0.12</td>
              </tr>
              <tr>
                <td align="left" valign="middle">CRP</td>
                <td align="center" valign="middle">62.6 &#177; 34.3</td>
                <td align="center" valign="middle">74 &#177; 38</td>
                <td align="center" valign="middle">0.03</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">WBC (10<sup><xref ref-type="bibr" rid="B3">3</xref></sup>/uL)</td>
                <td align="center" valign="middle">10.08 &#177; 3.5</td>
                <td align="center" valign="middle">11.7 &#177;4.7</td>
                <td align="center" valign="middle">0.02</td>
              </tr>
              <tr>
                <td align="left" valign="middle">Neutrophil (10<sup><xref ref-type="bibr" rid="B3">3</xref></sup>/uL)</td>
                <td align="center" valign="middle">8.6&#177; 0.9</td>
                <td align="center" valign="middle">8.9 &#177;1.3</td>
                <td align="center" valign="middle">0.45</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">Hemoglobin (g/dL)</td>
                <td align="center" valign="middle">10.5 &#177; 1.2</td>
                <td align="center" valign="middle">11 &#177; 1.3</td>
                <td align="center" valign="middle">0.60</td>
              </tr>
              <tr>
                <td align="left" valign="middle">Platelet (10<sup><xref ref-type="bibr" rid="B3">3</xref></sup>/uL)</td>
                <td align="center" valign="middle">311.4 &#177; 37</td>
                <td align="center" valign="middle">369.1 &#177; 38</td>
                <td align="center" valign="middle">0.25</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">LVEF (%)</td>
                <td align="center" valign="middle">53.4 &#177; 7.6</td>
                <td align="center" valign="middle">51.5 &#177; 8.1</td>
                <td align="center" valign="middle">0.18</td>
              </tr>
              <tr>
                <td align="left" valign="middle">Left atrium diameter (mm)</td>
                <td align="center" valign="middle">44.2 &#177; 4.1</td>
                <td align="center" valign="middle">47.2 &#177; 5.2</td>
                <td align="center" valign="middle">0.09</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">LVSWT (mm)</td>
                <td align="center" valign="middle">10.3 &#177; 1.3</td>
                <td align="center" valign="middle">9.9 &#177; 2.1</td>
                <td align="center" valign="middle">0.51</td>
              </tr>
              <tr>
                <td align="left" valign="middle">PWT (mm)</td>
                <td align="center" valign="middle">9.2 &#177; 1.5</td>
                <td align="center" valign="middle">9.6 &#177; 1.8</td>
                <td align="center" valign="middle">0.89</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">LVEDD (mm)</td>
                <td align="center" valign="middle">48.9 &#177; 4.1</td>
                <td align="center" valign="middle">51.1 &#177; 3.9</td>
                <td align="center" valign="middle">0.13</td>
              </tr>
              <tr>
                <td align="left" valign="middle">LVESD (mm)</td>
                <td align="center" valign="middle">33.9 &#177; 3.4</td>
                <td align="center" valign="middle">33.4 &#177; 3.5</td>
                <td align="center" valign="middle">0.57</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">TCBI</td>
                <td align="center" valign="middle">3413.3&#177;1232</td>
                <td align="center" valign="middle">1790.8 &#177; 689</td>
                <td align="center" valign="middle">&lt;0.001</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN3">
              <p>POAF: postoperative atrial fibrillation; BMI: body mass index; Na: sodium; K: potassium; AST: aspartate aminotransferase; ALT: alanine aminotransferase; LDL-C: low-density lipoprotein cholesterol; CRP: C-reactive protein; WBC: White blood cell; LVEF: left ventricular ejection fraction; LVSWT: left ventricular septal wall thickness; PWT: posterior wall thickness LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; TCBI: triglyceride, total cholesterol, and body weight index.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Univariate and multivariate Cox regression analysis was performed to identify independent variables predicting POAF. According to multiple Cox regression analyses, age and TCBI were determined as strong independent predictors of POAF after CABG surgery (<xref ref-type="table" rid="t4">Table 2</xref>).</p>
        <table-wrap id="t4">
          <label>Table 2</label>
          <caption>
            <title>The univariate and multivariate Cox regression analysis for predicting POAF</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup width="20%">
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
            </colgroup>
            <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
              <tr style="background-color:#76B4D0;">
                <th align="left" valign="middle"/>
                <th align="center" colspan="2" style="border-bottom: thin solid; border-color: #000000" valign="middle">Univariate</th>
                <th align="center" colspan="2" style="border-bottom: thin solid; border-color: #000000" valign="middle">Multivariate</th>
              </tr>
              <tr style="background-color:#76B4D0;">
                <th align="left" valign="middle"/>
                <th align="center" valign="middle">Odds Ratio (%95 CI)</th>
                <th align="center" valign="middle">p-value</th>
                <th align="center" valign="middle">Odds Ratio (%95 CI)</th>
                <th align="center" valign="middle">p-value</th>
              </tr>
            </thead>
            <tbody style="border-bottom: thin solid; border-color: #000000">
              <tr>
                <td align="left" valign="middle">Age</td>
                <td align="center" valign="middle">1.060 (1.029 &#8211; 1.091)</td>
                <td align="center" valign="middle">&lt;0.001</td>
                <td align="center" valign="middle">1.046 (1.014-1.080)</td>
                <td align="center" valign="middle">0.005</td>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">TCBI</td>
                <td align="center" valign="middle">0.997 (0.996 &#8211; 0.999)</td>
                <td align="center" valign="middle">&lt;0.001</td>
                <td align="center" valign="middle">0.998 (0.997-0.999)</td>
                <td align="center" valign="middle">&lt;0.001</td>
              </tr>
              <tr>
                <td align="left" valign="middle">Hypertension</td>
                <td align="center" valign="middle">2.599 (1.241 &#8211; 5.445)</td>
                <td align="center" valign="middle">0.011</td>
                <td align="center" valign="middle"/>
                <td align="center" valign="middle"/>
              </tr>
              <tr style="background-color:#C7DFEC;">
                <td align="left" valign="middle">CRP</td>
                <td align="center" valign="middle">1.007 (1.001 &#8211; 1.014)</td>
                <td align="center" valign="middle">0.024</td>
                <td align="center" valign="middle"/>
                <td align="center" valign="middle"/>
              </tr>
              <tr>
                <td align="left" valign="middle">WBC</td>
                <td align="center" valign="middle">1.091 (1.031 &#8211; 1.154)</td>
                <td align="center" valign="middle">0.003</td>
                <td align="center" valign="middle"/>
                <td align="center" valign="middle"/>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN4">
              <p>POAF: postoperative atrial fibrillation; TCBI: triglyceride, total cholesterol, and body weight index; CRP: C-reactive protein; WBC: white blood cell.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>In ROC analysis, TCBI &lt; 1932.4 was found to predict POAF with 75% sensitivity and 78% specificity (<xref ref-type="fig" rid="f02001">Figure 1</xref>).</p>
        <fig id="f02001">
          <label>Figure 1</label>
          <caption>
            <title>ROC curve of Triglyceride-Cholesterol-Body Weight Index (TCBI).</title>
          </caption>
          <graphic xlink:href="1678-4170-abc-122-04-e20240607-40607-gf02-en.tif"/></fig>
      </sec>
      <sec sec-type="discussion">
        <title>Discussion</title>
        <p>This comprehensive study investigates the relationship between CABG surgery and POAF. The most significant finding of our study is that the TCBI was identified as an independent predictor of POAF.</p>
        <p>Historically, AF was not considered a major complication following cardiac surgery. However, subsequent studies have demonstrated that POAF significantly impacts both mortality and morbidity.<sup><xref ref-type="bibr" rid="B15">15</xref></sup> For instance, a study conducted with CABG patients revealed that those who developed POAF experienced longer durations on mechanical ventilation, as well as prolonged stays in the intensive care unit and hospital.<sup><xref ref-type="bibr" rid="B16">16</xref></sup> Additionally, POAF has been associated with an increased long-term risk of mortality and stroke.<sup><xref ref-type="bibr" rid="B17">17</xref></sup></p>
        <p>In our study, it was observed that patients with low TCBI levels had a higher risk of POAF in the postoperative period. In the literature, the impact of nutritional status on surgical outcomes has been frequently emphasized, and it has been shown that malnutrition slows down the recovery process and increases the risk of complications.<sup><xref ref-type="bibr" rid="B18">18</xref></sup> Given the role of inflammation in the development of AF, it is thought that poor nutritional status may exacerbate this process. Malnutrition has been shown to increase cardiovascular events and complications after cardiovascular surgery.<sup><xref ref-type="bibr" rid="B19">19</xref></sup> TCBI not only predicts complications like POAF but also serves as a sensitive indicator of nutritional status. This finding suggests that patients with poor nutritional status may require more intensive nutritional support during the preoperative period. Furthermore, our study confirms that compared to other nutritional indicators, TCBI more specifically reflects malnutrition and the risk of complications. A better understanding of the relationship between nutritional status and POAF could contribute to the development of personalized nutritional approaches in these patients, potentially reducing postoperative complications and improving overall health outcomes. Improving nutritional status could also alleviate the burden on healthcare systems by reducing postoperative complications in the long term.</p>
        <p>Given the potential for POAF to lead to serious postoperative complications, identifying patients at high risk for AF has become a critical goal. This understanding has driven researchers to conduct more comprehensive studies on the risk factors associated with POAF. It is well known that poor nutritional status triggers inflammation, which may pave the way for complications such as AF after surgery. Nutritional indices such as TCBI are considered important tools in predicting these complications, and preventive nutritional interventions may be applied, particularly in high-risk patients.</p>
        <p>Several studies have highlighted factors that may contribute to the development of POAF. Hypoxemia has been identified as a significant risk factor for POAF,<sup><xref ref-type="bibr" rid="B20">20</xref></sup> while other research has demonstrated a correlation between various surgical techniques and the incidence of POAF.<sup><xref ref-type="bibr" rid="B21">21</xref></sup> Risk factors such as advanced age, increased left atrial (LA) diameter, reduced ejection fraction (EF), chronic obstructive pulmonary disease (COPD), hypertension, myocardial infarction, and diabetes have all been associated with POAF development, as supported by a meta-analysis involving 36,834 patients.<sup><xref ref-type="bibr" rid="B22">22</xref></sup></p>
        <p>The value of TCBI as a significant predictor of outcomes in various diseases, particularly cardiovascular conditions, has been increasingly recognized. Research has shown that low TCBI levels are strongly associated with all-cause mortality and cardiovascular mortality in patients with coronary artery disease.<sup><xref ref-type="bibr" rid="B4">4</xref></sup> Furthermore, TCBI is recommended for assessing the nutritional status of cardiovascular patients, as it has proven to be a strong predictor of poor prognosis and mortality in both cardiovascular patients and the general population.<sup><xref ref-type="bibr" rid="B4">4</xref></sup> In our study, TCBI was found to be a significant predictor of postoperative AF in patients undergoing CABG surgery.</p>
        <p>Inflammatory markers also play a significant role in the development of AF. Many studies have shown that patients with AF tend to have higher levels of inflammatory markers compared to those in SR.<sup><xref ref-type="bibr" rid="B23">23</xref></sup> Additionally, C-reactive protein (CRP) levels have been shown to predict the development of new-onset AF.<sup><xref ref-type="bibr" rid="B24">24</xref></sup> In our study, elevated white blood cell (WBC) counts and CRP levels in the group that developed POAF suggest that an inflammatory mechanism may be contributing to the onset of AF.</p>
        <p>Age has consistently been identified as an independent risk factor for the development of AF. One study estimated that the prevalence of AF in elderly patients in the European Union would more than double after the age of 50.<sup><xref ref-type="bibr" rid="B25">25</xref></sup> Our findings align with these observations, as we identified advanced age as one of the most significant risk factors for the development of POAF.</p>
        <sec>
          <title>Limitations</title>
          <p>The most important limitation of the study is that it is retrospective. Lack of sufficient knowledge about the surgical techniques applied is also an important limitation. We also do not have data on the anesthetic drugs given to patients before surgery. The anesthetic agents given may also have changed this parameter. Multicenter, prospective, randomized controlled studies are needed to understand better whether this parameter is predictive of POAF.</p>
        </sec>
      </sec>
      <sec sec-type="conclusions">
        <title>Conclusions</title>
        <p>TCBI can predict the development of POAF in patients undergoing CABG. With the help of this parameter, patients who need to receive prophylactic treatment before CABG can be determined, thus reducing mortality and morbidity.</p>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn fn-type="financial-disclosure" id="fn4">
          <label>Sources of funding</label>
          <p>There were no external funding sources for this study.</p>
        </fn>
        <fn fn-type="other" id="fn5">
          <label>Study association</label>
          <p>This study is not associated with any thesis or dissertation work.</p>
        </fn>
        <fn fn-type="other" id="fn6">
          <label>Ethics approval and consent to participate</label>
          <p>This study was approved by the Ethics Committee of the Bakircay University under the protocol number 1918. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013.</p>
        </fn>
      </fn-group>
    </back>
  </sub-article>
</article>
